- The trend backdrop is active with a 7-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
ARGX
BRU
Week ended 07 Aug 2026
Weekly Investor Report
argenx SE · Healthcare · Biotechnology
Latest close
763.2 EUR
2.4%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 7.8% above the Trend Line and sits at 76.1% of its 52-week range. The latest completed week returned 2.4%, after a -0.1% four-week move. The latest news-sentiment score is 51/100.
Setup score
52
out of 100
Latest Close
763.2 EUR
7 Aug 2026
1W Return
2.4%
latest completed week
4W Return
-0.1%
short-term follow-through
12W Return
10.1%
quarterly tape
Trend Breadth
61.5%
32 of 52 weeks active
Volume Ratio
1.3x
vs 13-week average
- 4 reversal markers appear in the recent smart-money tape.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
2.4%
Latest completed week; four-week move -0.1%.
Indicator stack
58/57
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
51/100
17 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 7.8% above the Trend Line and sits at 76.1% of its 52-week range. The latest completed week returned 2.4%, after a -0.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.3x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.8312-week average 0.53
12-week confirmation
Trend active7/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership8/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.83Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers44 reversal markers
No recent accumulation markers. 4 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -0.1% over four weeks, 10.1% over 12 weeks, and 34.3% over one year. The current trend has remained active for 7 consecutive weeks.
Performance by holding period
Active trend streak7 weeks
Active weeks in one year32
Trend breadth61.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.57Latest activity-pressure read.
Pressure change-41.9%Four-week change in activity pressure.
Leadership-1.16Latest relative-leadership reading.
RS change-135.9%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment51/100
Weighted news tone is neutral across 17 relevant articles.
4 positive · 13 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-8.3%Distance below the 52-week high.
13-week volatility4.6%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher17 of 269 weeks finished lower.
Best week+7.0%Week of 5 Jun.
Worst week-9.0%Week of 27 Feb.
Latest week+2.4%Week of 7 Aug.
Shape of recent returns
Strong gains6
Modest gains11
Flat weeks0
Modest losses3
Sharp losses6
Recent vol4.6%13-week weekly-return volatility.
Base vol4.2%52-week weekly-return volatility.
Up/down split31/20Count of positive and negative weeks in the 52-week window.
Average skew3.4% / -3.5%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorBE Healthcare
4-week rank3 / 12
Group average-2.8%
Trend breadth25.0%
Trend25.0%active weekly trend signals
MD25.0%positive activity pressure
RS8.3%positive relative leadership
Four-week leaders
IndustryBE Biotechnology
4-week rank3 / 9
Group average-1.1%
Trend breadth11.1%
Trend11.1%active weekly trend signals
MD22.2%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape51/100
Trend, activity pressure, participation, and risk combine to a 51/100 tape read.
Indicator analysis64/100Latest 12-week confirmation: trend 7/12, activity pressure 12/12, relative leadership 8/12.
Activity pressure 0.83; 4 reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment51/100Weighted news tone is neutral across 17 relevant articles.
argenx (ENXTBR:ARGX) Is Considering A Forte Biosciences Acquisition Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 763.2 EUR | 2.4% | 708.0 EUR | 547.6 EUR | 0.57 | -1.16 | 417.7K | On |
| 31 Jul 2026 | 745.0 EUR | -7.4% | 705.7 EUR | 545.6 EUR | 0.71 | -1.79 | 451.4K | On |
| 24 Jul 2026 | 804.4 EUR | 7.0% | 705.0 EUR | 543.7 EUR | 0.91 | 5.19 | 480.0K | On |
| 17 Jul 2026 | 752.0 EUR | -1.5% | 702.1 EUR | 541.5 EUR | 0.88 | 0.61 | 335.8K | On |
| 10 Jul 2026 | 763.8 EUR | -8.1% | 701.6 EUR | 539.8 EUR | 0.98 | 3.23 | 422.7K | On |
| 3 Jul 2026 | 830.8 EUR | 5.9% | 701.2 EUR | 537.1 EUR | 0.95 | 8.52 | 41.2K | On |
| 26 Jun 2026 | 784.4 EUR | 1.4% | 699.2 EUR | 534.0 EUR | 0.81 | 4.37 | 77.1K | On |
| 19 Jun 2026 | 773.8 EUR | -1.3% | 699.1 EUR | 531.2 EUR | 0.76 | 5.10 | 291.6K | Off |
| 12 Jun 2026 | 783.6 EUR | 2.3% | 700.0 EUR | 528.6 EUR | 0.59 | 5.25 | 88.3K | Off |
| 5 Jun 2026 | 766.0 EUR | 7.0% | 699.9 EUR | 525.9 EUR | 0.43 | 6.18 | 149.2K | Off |
| 29 May 2026 | 715.6 EUR | 2.1% | 698.7 EUR | 523.3 EUR | 0.28 | -0.53 | 598.7K | Off |
| 22 May 2026 | 701.0 EUR | 1.1% | 698.4 EUR | 521.1 EUR | 0.02 | -2.45 | 371.4K | Off |
| 15 May 2026 | 693.2 EUR | 3.3% | 698.4 EUR | 519.0 EUR | -0.15 | -1.23 | 388.1K | Off |
| 8 May 2026 | 670.8 EUR | 0.4% | 699.0 EUR | 517.0 EUR | -0.17 | -4.16 | 488.5K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.